NASDAQ:CRSP | Operating Income | CRISPR Therapeutics AG

Complete source-backed operating income history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$117.27M
2026-03-31-$130.25M
2025-12-31-$154.76M
2025-09-30-$132.06M
2025-06-30-$229.32M
2025-03-31-$148.42M
2024-12-31-$64.59M
2024-09-30-$110.13M
2024-06-30-$151.26M
2024-03-31-$140.59M
2023-12-31$69.58M
2023-09-30-$132.41M
2023-06-30-$95.22M
2023-03-31-$64.49M
2022-12-31-$131.54M
2022-09-30-$182.39M
2022-06-30-$183.26M
2022-03-31-$175.97M
2021-12-31-$145.7M
2021-09-30-$128.85M
2021-06-30$762.62M
2021-03-31-$114.54M
2020-12-31-$107.76M
2020-09-30-$92.4M
2020-06-30-$80.69M
2020-03-31-$73.59M
2019-12-31$10.98M
2019-09-30$139.16M
2019-06-30-$54.98M
2019-03-31-$48.42M
2018-12-31-$45.23M
2018-09-30-$49.43M
2018-06-30-$37.29M
2018-03-31-$27M
2017-12-31$972,000.00
2017-09-30-$23.57M
2017-06-30-$21.31M
2017-03-31-$20.74M
2016-12-31-$25.31M
2016-09-30-$14.61M
2016-06-30-$16.56M
2016-03-31-$11.65M
2015-12-31-$12.17M
2015-09-30-$6.2M

Annual Operating Income

DateOperating Income
2025-12-31-$664.57M
2024-12-31-$466.57M
2023-12-31-$222.54M
2022-12-31-$673.16M
2021-12-31$373.53M
2020-12-31-$354.44M
2019-12-31$46.74M
2018-12-31-$158.94M
2017-12-31-$64.65M
2016-12-31-$68.13M
2015-12-31-$25.73M
2014-12-31-$6.63M